+ EDUCATION Abstract This scoping review directs attention to artificial intelligence–mediated informal language learning…± HEALTH Artificial intelligence (AI) is increasingly being integrated into healthcare systems and has the potential t…± HEALTH Objective This article helps neurologists understand modern approaches to diagnosing obstructive sleep apnea,…± CLIMATE Antifouling paints often contain biocides designed to inhibit biological growth, and antifouling paint partic…+ EDUCATION Generative artificial intelligence (GenAI) tools are an increasingly common resource used in the classroom an…+ HEALTH Objective Compare the effectiveness of machine learning algorithms and traditional logistic regression in pre…± HEALTH Objective Given the pivotal role of imaging in diagnosing urological cancers, artificial intelligence (AI) ha…+ HEALTH Background Traumatic cervical spinal cord injury (TCSCI) often causes severe neurological dysfunction. Accura…
TruaceTracing the truth around AIWednesday, August 5, 2026
Subscribe
Health·G Space·Evidence-backed gain·Published 2026-08-01

Multiomics Profiling Identifies Blood-Based Diagnostic Markers for Sepsis

Sepsis, characterized by a rapid transition to systemic immune dysregulation and multiorgan failure, poses a formidable clinical challenge. The lack of spatiotemporally stable biomarkers severely impedes early diagnosis and risk stratification. By integrating large-scale transcriptomic profiling with machine learning algorithms, this study identified a robust three-gene diagnostic signature (TLR5, HMGB2, and C19orf59). Single-cell RNA sequencing precisely localized the sepsis-induced specific upregulation of the…

TRV-2026-0615Peer-reviewedPermanent record — cite & verify
Multiomics Profiling Identifies Blood-Based Diagnostic Markers for Sepsis

Hospital Universitari Doctor Peset, València 06 by 19Tarrestnom65. CC BY-SA 4.0 · https://creativecommons.org/licenses/by-sa/4.0

The quick read

By August 1, 2026, researchers reported integrating large-scale transcriptomic profiling with machine learning to identify TLR5, HMGB2, and C19orf59 as a blood-based diagnostic signature for sepsis. They mapped expression to myeloid cells and tested the panel across SOFA-defined severity strata, then validated it in sham-controlled CLP mice, LPS-stimulated cells, and sepsis patient serum.

The work matters because sepsis lacks spatiotemporally stable biomarkers for early diagnosis, and a reliable blood panel could improve triage and risk stratification. What remains uncertain from this text is prospective clinical performance, generalizability beyond the studied cohorts, and how the signature would integrate into existing diagnostic workflows.

Main points
  • Machine learning on transcriptomic data identified TLR5, HMGB2, and C19orf59 as a diagnostic signature for sepsis.
  • Single-cell RNA sequencing localized upregulation to monocytes and neutrophils in the myeloid compartment.
  • Validation included sham-controlled CLP murine models, LPS-stimulated cell models, and independent sepsis patient serum.
Gain

Integrating large-scale transcriptomic profiling with machine learning identified a three-gene blood signature that enables early sepsis diagnosis and risk stratification across severity levels.

The rundown

The study combined large-scale transcriptomic profiling with machine learning to derive the three-gene panel, then used single-cell RNA sequencing to localize expression to monocytes and neutrophils. Severity analysis based on SOFA scores showed TLR5 and HMGB2 excel in high-risk cases while C19orf59 maintains efficacy across all strata.

Validation was multidimensional: strictly time-matched sham-controlled cecal ligation and puncture murine models showed persistent upregulation across lung, heart, liver and systemic circulation, and vehicle-controlled in vitro LPS models revealed HMGB2 exhibiting a distinct biphasic kinetic profile characteristic of DAMPs, followed by clinical validation in patient serum.

Sources

Reader signal

How should this claim be treated?

The debate